<DOC>
	<DOCNO>NCT00970606</DOCNO>
	<brief_summary>To assess efficacy safety oral rosuvastatin patient suspect confirmed influenza require intensive care unit ( ICU ) admission due respiratory distress .</brief_summary>
	<brief_title>STIP : Statin Trial Influenza Patients</brief_title>
	<detailed_description>Hypothesis : Rosuvastatin therapy improve mortality reduce need mechanical ventilation patient experience respiratory distress complication influenza .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>1 . Patients suspect confirmed influenza ( Appendix A ) 2 . Requirement ICU ( ICU stepdown ) admission due respiratory distress define : SaO2/FiO2 &lt; 315 PaO2/FiO2 &lt; 300 Multiply PB/760 ( altitude exceed 51000 ft ) For FiO2 nonintubated patient see Appendix B Participants must receive first dose study drug within 48 hour follow ICU admission confirm suspected influenza exclude participation study . 1 . No consent/inability obtain consent 2 . Age le 13 year 3 . Weight le 40 kg 4 . Unable receive unlikely absorb enteral study drug ( e.g . patient partial complete mechanical bowel obstruction , intestinal ischemia , infarction , short bowel syndrome ) 5 . Allergy intolerance statins* 6 . Pregnancy breast feed 7 . Receiving niacin , fenofibrate , cyclosporine , gemfibrozil , antiviral protease inhibitor include limited lopinavir ritonavir . 8 . Existing clinically significant myositis myopathy measure CK great 5,000 U/L 9 . Requiring statin underlying disease determine patient attend physician team** . 10 . Severe chronic liver disease ( ChildPugh Score 1115 ) 11 . Previous myocardial infarction thrombotic stroke within past 6 month 11.12 . Any significant funding patient 's medical history physical psychiatric exam prior randomization , opinion investigator , would affect patient safety compliance ability deliver study drug accord protocol</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>ARDS</keyword>
	<keyword>H1N1</keyword>
	<keyword>Influenza</keyword>
	<keyword>Statin</keyword>
</DOC>